Skip to content

Disc Medicine IRON Interest Expense

Interest Expense at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$10.8M-32.9%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$2.3M-19.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$12.94M-28.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$49.03M-43.8%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's interest expense?
Disc Medicine (IRON) reported interest expense of $844K in Q1 2026.
How has Disc Medicine's interest expense changed year-over-year?
Disc Medicine's interest expense decreased by 5.9% year-over-year, from $897K to $844K.
What is the long-term trend for Disc Medicine's interest expense?
Over 3 years (2021 to 2025), Disc Medicine's interest expense has grown at a 18.7% compound annual growth rate (CAGR), from $2.16M to $3.61M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.